Coverage, price, and reimbursement for multigene tests for cancer and related conditions
The objective of this award is to examine “coverage, price, and reimbursement” (“CPR”) for cancer risk multigene tests (panels and sequencing tests): what tests are covered by payers, why are tests covered or not covered, and how CPR influences testing decisions and practices in clinic settings.
Funding: NIH/NCI (R01CA221870)
Timeframe: 07/01/2018 – 06/30/2021
Risk-benefit trade-offs for whole genome sequencing
The objective of this award is to evaluate the benefit-risk trade-offs of genomic sequencing technologies from an individual perspective -how patients make decisions about sequencing and from a societal perspective - how sequencing may impact the health care system.
Funding: NHGRI (R01HG007063)
Timeframe: 02/15/2013 – 01/31/2019
Genomic sequencing to aid diagnosis in pediatric and prenatal practice
The center grant will focus on generating and analyzing evidence regarding the clinical utility of genome sequencing from the perinatal period into early childhood through examining clinical utility, ethical implications, payer coverage, and data integration in a diverse population.
Funding: NIH/NHGRI (U01HG009599)
Timeframe: 08/01/2017 – 05/31/2021
Developing evidence on reimbursement for the UCSF500 tumor profiling panel test
Our objective is to collect evidence on reimbursement challenges for Cancer Tumor Profiling (UCSF500) tests and explore how those challenges could be addressed. The goal is to obtain preliminary data and develop a multi-disciplinary team of collaborators that can compete for larger grant funding.
Funding: NUCSF Research Administration Program
Timeframe: 07/01/2017 – 8/15/2018